Literature DB >> 26235493

Homozygous losses detected by array comparative genomic hybridization in multiplex urothelial carcinomas of the bladder.

Tamas Beothe1, Dmitry Zubakov2, Gyula Kovacs3.   

Abstract

Urothelial carcinomas (UCs) may present at first as a solitary or multifocal neoplasm. We applied high resolution array comparative genomic hybridization to 24 solitary and 32 multiplex UCs and used the hidden Markov model algorithm to identify the copy number changes at the probe level. Copy number losses and homozygous deletions at the chromosome 9p region affecting the CDKN2A and MTAP genes were the most frequent alterations in both groups of tumors. We have delineated two new tumor suppressor gene regions at chromosome 9p that harbor the PTPRD and BNC2 genes. Copy number losses at chromosomal regions 2q, 8p, and 18p occurred preferentially in solitary UCs, whereas multiplex UCs displayed loss of large chromosomal regions at 9q, 10q, 11q, 18q, and 21q. Homozygous deletions harboring loci of cell adhesion genes such as claudins, desmocollins, and desmogleins were seen exclusively in multiplex UCs. Amplifications occurred only in invasive G3 UCs irrespective of staging. Our study suggests that solitary and multiplex UCs may have divergent genetic pathways. The biallelic inactivation of cellular adhesion genes by homozygous deletions in multiplex UCs may explain the frequent intravesical spreading of tumor cells. .
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  array comparative genomic hybridization; cell adhesion; homozygous loss; multiplex tumors; urothelial carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26235493     DOI: 10.1016/j.cancergen.2015.05.029

Source DB:  PubMed          Journal:  Cancer Genet


  6 in total

1.  Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy.

Authors:  Brian R Winters; Navonil De Sarkar; Sonali Arora; Hamid Bolouri; Sujata Jana; Funda Vakar-Lopez; Heather H Cheng; Michael T Schweizer; Evan Y Yu; Petros Grivas; John K Lee; Lori Kollath; Sarah K Holt; Lisa McFerrin; Gavin Ha; Peter S Nelson; Robert B Montgomery; Jonathan L Wright; Hung-Ming Lam; Andrew C Hsieh
Journal:  JCI Insight       Date:  2019-05-30

2.  Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.

Authors:  Rongkang Li; Yong Xia; Xuan Chen; Xinji Li; Guocheng Huang; Xiqi Peng; Kaihao Liu; Chunduo Zhang; Mingyang Li; Yu Lin; Jing Dong; Ling Ji; Yongqing Lai
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

3.  Circular_0086414 induces SPARC like 1 (SPARCL1) production to inhibit esophageal cancer cell proliferation, invasion and glycolysis and induce cell apoptosis by sponging miR-1290.

Authors:  Qingfeng Jiang; Haoran Wang; Dongfeng Yuan; Xin Qian; Xiaochao Ma; Ming Yan; Wenqun Xing
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.

Authors:  Laura Cesaratto; Eleonora Grisard; Michela Coan; Luigi Zandonà; Elena De Mattia; Elena Poletto; Erika Cecchin; Fabio Puglisi; Vincenzo Canzonieri; Maria Teresa Mucignat; Antonella Zucchetto; Gabriele Stocco; Alfonso Colombatti; Milena S Nicoloso; Riccardo Spizzo
Journal:  Cell Death Dis       Date:  2016-09-22       Impact factor: 8.469

5.  PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients.

Authors:  Hung-Chih Hsu; Nina Lapke; Shu-Jen Chen; Yen-Jung Lu; Ren-Shiang Jhou; Chien-Yuh Yeh; Wen-Sy Tsai; Hsin-Yuan Hung; Jason Chia-Hsun Hsieh; Tsai-Sheng Yang; Tan Kien Thiam; Jeng-Fu You
Journal:  Cancers (Basel)       Date:  2018-09-06       Impact factor: 6.639

6.  Protein tyrosine phosphatase receptor type delta (PTPRD) suppresses the expression of PD-L1 in human hepatocellular carcinoma by down-regulating STAT3.

Authors:  Qiuhua Meng; Jing Tian; Feizhang Qin; Xuejing Huang; Dan Zhu; Bangde Xiang; Min Dong
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.